Melanoma differentiation-associated 7 (interleukin 24) inhibits growth and enhances radiosensitivity of glioma cells in vitro and in vivo

被引:0
|
作者
Yacoub, A
Mitchell, C
Lister, A
Lebedeva, IV
Sarkar, D
Su, ZZ
Sigmon, C
McKinstry, R
Ramakrishnan, V
Qiao, L
Broaddus, WC
Gopalkrishnan, RV
Grant, S
Fisher, PB
Dent, P
机构
[1] Virginia Commonwealth Univ, Dept Radiat Oncol, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23298 USA
[3] Virginia Commonwealth Univ, Dept Med, Richmond, VA 23298 USA
[4] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA
[5] Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA
[6] Columbia Univ Coll Phys & Surg, Dept Neurosurg, New York, NY 10032 USA
[7] Columbia Univ Coll Phys & Surg, Dept Urol, New York, NY 10032 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Despite therapeutic interventions including surgery, chemotherapy, and radiotherapy, glioblastoma multiforme (GBM) has a very poor prognosis and novel therapies are required. Experimental Design: Melanoma differentiation-associated 7 (mda-7) (interleukin 24), when expressed via a recombinant replication-defective adenovirus, adenovirus (Ad).mda-7, has profound antiproliferative and cytotoxic effects in a variety of tumor cells but not in nontransformed cells. The present studies examined the combined impact of Ad.mda-7 and ionizing radiation on the proliferation and survival of GBM cell lines. Results: Ad.mda-7 caused a dose-dependent reduction in the proliferation of glioma cells in 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays. The antiproliferative effects of Ad.mda-7 were enhanced by radiation in a greater than additive fashion. These effects were not observed in cultures of nontransformed primary astrocytes. Purified MDA-7 protein caused a similar dose-dependent reduction in GBM cell growth that was enhanced after radiation exposure. The enhanced reduction in growth correlated with increased necrosis and DNA degradation. These modifications in cell.phenotype correlated with reduced expression of Bcl-(XL) and enhanced expression of BAX. Overexpression of Bcl-(XL) protected cells from the antiproliferative and cytotoxic effects of Ad.mda-7 + radiation. Incubation of cells with N-acetyl cysteine abolished the enhancing effects of radiation. In vitro, Ad.mda-7 and radiation reduced colony formation ability, which was significantly increased when the two treatments were combined. In vivo, Ad.mda-7 enhanced the survival of Fischer 344 rats implanted intracranially with glioma cells. Radiation did not alter survival in control infected animals, whereas it prolonged survival in those infected with Ad.mda-7. Conclusions: These findings demonstrate that mda-7 reduces the proliferation and enhances the radiosensitivity of GBM cells in vitro and in vivo.
引用
收藏
页码:3272 / 3281
页数:10
相关论文
共 50 条
  • [21] The proteasome inhibitor bortezomib inhibits the growth of canine malignant melanoma cells in vitro and in vivo
    Ito, Keita
    Kobayashi, Masato
    Kuroki, Shiori
    Sasaki, Yu
    Iwata, Taisuke
    Mori, Kohei
    Kuroki, Tetsuya
    Ozawa, Yuta
    Tetsuka, Masanori
    Nakagawa, Tomoko
    Hiroi, Teruyo
    Yamamoto, Hitomi
    Ono, Kenichiro
    Washizu, Tsukimi
    Bonkobara, Makoto
    VETERINARY JOURNAL, 2013, 198 (03): : 577 - 582
  • [22] The Soy-Derived Peptide Lunasin Inhibits the Growth of Melanoma Cells in Vitro and in Vivo
    AL Rayyan, Numan
    Shidal, Chris
    Yaddanapudi, Kavitha
    Keith, Davis
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [23] Ivermectin inhibits the growth of glioma cells by inducing cell cycle arrest and apoptosis in vitro and in vivo
    Song, Dandan
    Liang, Hongsheng
    Qu, Bo
    Li, Yijing
    Liu, Jingjing
    Zhang, Yanan
    Li, Lu
    Hu, Li
    Zhang, Xiangtong
    Gao, Aili
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (01) : 622 - 633
  • [24] Histone Deacetylase Inhibitors Interact with Melanoma Differentiation Associated-7/Interleukin-24 to Kill Primary Human Glioblastoma Cells
    Hamed, Hossein A.
    Yacoub, Adly
    Park, Margaret A.
    Archer, Kellie
    Das, Swadesh K.
    Sarkar, Devanand
    Grant, Steven
    Fisher, Paul B.
    Dent, Paul
    MOLECULAR PHARMACOLOGY, 2013, 84 (02) : 171 - 181
  • [25] Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo
    Javelaud, D
    Delmas, V
    Möller, M
    Sextius, P
    André, J
    Menashi, S
    Larue, L
    Mauviel, A
    ONCOGENE, 2005, 24 (51) : 7624 - 7629
  • [26] Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo
    Delphine Javelaud
    Véronique Delmas
    Maria Möller
    Peggy Sextius
    Jocelyne André
    Suzanne Menashi
    Lionel Larue
    Alain Mauviel
    Oncogene, 2005, 24 : 7624 - 7629
  • [27] Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo
    Javelaud, D
    Moller, M
    Sextius, P
    Delmas, V
    Menashi, S
    Larue, L
    Mauviel, A
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (04) : A146 - A146
  • [28] Reversal Effect of Melanoma Differentiation Associated Gene-7/Interleukin-24 on Multidrug Resistance in Human Hepatocellular Carcinoma Cells
    Fang, Ping
    Zhang, Xin
    Gao, Yan
    Ding, Chang-Rui
    Cui, Fang
    Jiao, Shun-Chang
    ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2012, 295 (10): : 1639 - 1646
  • [29] Stable overexpression of Smad7 inhibits the tumorigenicity of in human melanoma cells in vitro and in vivo
    Javelaud, D
    Delmas, V
    Sextius, P
    Moller, M
    Menashi, S
    Larue, L
    Mauviel, A
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (03) : A61 - A61
  • [30] Melanoma differentiation-associated gene-7/interleukin-24 as a potential prognostic biomarker and second primary malignancy indicator in head and neck squamous cell carcinoma patients
    Wang, Lin
    Feng, Zhien
    Wu, Huanhuan
    Zhang, Shuai
    Pu, Yinfei
    Bian, Huan
    Wang, Yixiang
    Guo, Chuanbin
    TUMOR BIOLOGY, 2014, 35 (11) : 10977 - 10985